Detailed Explanation
Synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a modified analog of the naturally occurring immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with a Pro-Gly-Pro extension that improves metabolic stability. Selank is studied for anxiolytic (anti-anxiety) and nootropic (cognitive-enhancing) effects.
It is approved as a nasal spray in Russia for generalized anxiety disorder. Research suggests it modulates brain-derived neurotrophic factor (BDNF) expression and serotonin metabolism. Selank is not FDA-approved and is classified as a research compound outside of Russia.
Key Facts
- Synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences.
- It is a modified analog of the naturally occurring immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg) with a Pro-Gly-Pro extension that improves metabolic stability.
- Selank is studied for anxiolytic (anti-anxiety) and nootropic (cognitive-enhancing) effects.
- It is approved as a nasal spray in Russia for generalized anxiety disorder.
- Research suggests it modulates brain-derived neurotrophic factor (BDNF) expression and serotonin metabolism.
- Selank is not FDA-approved and is classified as a research compound outside of Russia.
Part of the PeptideBond.com education network
Educational Disclaimer
PeptideDefinition.com provides educational content about peptide science. Not medical advice. Consult a licensed healthcare provider for medical decisions.